Only the intravenous form of levocarnitine is indicated for use in ESRD patients on hemodialysis
This promising data of a chemical, nonpeptide molecule supports continued development of orforglipron as an oral treatment for obesity. Wharton said a phase 3 trial has begun to analyze orforglipron as a treatment for chronic weight management for treatment of obesity
As we age, our NAD+ levels decline, leading to decreased energy, cognitive decline, and signs of aging
Researchers also found that GHK-Cu injections could help mice recover more quickly from anterior cruciate ligament (ACL) reconstruction surgery by promoting tissue remodeling and growth of the graft (where the new tissue meets the old tissue), which tends to be the weakest link in recovery from such operations [5]
Regarding article, Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial